Study on the Interaction of Algal Peptides on Virulence Factors of Helicobacter pylori: In Silico Approach

Davoodbasha MubarakAli1, Thirusangu Akshaya2, Raghunathan Sathya2

  • 1School of Life Sciences, B.S. Abdur Rahman Crescent Institute of Science and Technology, Chennai, Tamil Nadu, India. mubinano@gmail.com.

Insights

Green algae peptides show promise in inhibiting Helicobacter pylori virulence factors, offering a potential new treatment for peptic ulcers and a preventative measure against gastric cancer. This discovery could lead to novel drug development.

Area of Science:

  • Biotechnology
  • Marine Biology
  • Computational Biology

Background:

  • Helicobacter pylori infection is highly prevalent in Asia, causing peptic ulcers and increasing gastric cancer risk.
  • Virulence factors like CagA, VacA, and HtrA in H. pylori strains are key contributors to severe complications.
  • Targeting these virulence factors presents a therapeutic strategy to combat H. pylori infections.

Purpose of the Study:

  • To investigate the antagonistic interactions between algal peptides and H. pylori virulence factors.
  • To identify potential peptide-based inhibitors for H. pylori through in silico analysis.
  • To explore novel treatments for peptic ulcers and gastric cancer prevention.

Main Methods:

  • In silico analysis was employed to study interactions between eight algal peptides and H. pylori virulence factors.
  • Molecular docking using the C-Docker algorithm was performed to assess binding affinities.
  • Binding energies of peptide-virulence factor complexes were calculated.

Main Results:

  • A peptide from the green alga Tetradesmus sp. demonstrated significant activity against CagA, VacA, and HtrA.
  • Effective interactions included hydrogen bonds, van der Waals, and electrostatic forces, with mild π-hydrophobic bindings.
  • Libdock energy scores for CagA, VacA, and HtrA complexes were 175.625, 158.603, and 89.397 kcal/mol, respectively.

Conclusions:

  • Algal peptides, particularly from Tetradesmus sp., show potential as effective inhibitors of H. pylori virulence factors.
  • These findings suggest a promising avenue for developing new therapeutic agents against H. pylori infections.
  • This research paves the way for novel treatments targeting peptic ulcers and preventing H. pylori-associated gastric cancer.

Related Concept Videos

Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
135
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
622
Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
780